Results 251 to 260 of about 213,311 (303)
Some of the next articles are maybe not open access.

Medicare Part D on the Front Line

Journal of Managed Care Pharmacy, 2006
Here are some of my observations from the first 4 months of Medicare Part D, as a community pharmacist working in a chain pharmacy in the Southwest. I may be in the minority of pharmacists with regard to Medicare D observations. But then again, my chain employer understandably keeps us totally in the dark regarding all aspects of reimbursement, so I ...
openaire   +2 more sources

Medication Therapy Management in Medicare Part D

The Senior Care Pharmacist, 2022
Medication Therapy Management (MTM) is not just a good idea–it is the law. Included in the provisions of the Medicare Modernization Act of 2003 and codified into the Social Security Act is the legal mandate for a program to identify at-risk individuals with chronic disease conditions and an expected consumption of Part D drugs that reached a ...
openaire   +2 more sources

Medicare Part D Data

Medical Care, 2007
The 3 primary administrative data sets developed by the Centers for Medicare and Medicaid services (CMS) to support the Medicare Part D program implementation represent a valuable source of data for health services researchers. This paper describes the structure of the Medicare Part D program and the related databases, and discusses their utilization ...
openaire   +2 more sources

Medicare Part D Redesign

2021
Policymakers have proposed redesigning Medicare Part D to protect beneficiaries from high out-of-pocket costs and reduce overall program spending.
openaire   +1 more source

The Impact of Medicare Part D on Self-Employment

Research on Aging, 2016
We explore the relationship between access to affordable health insurance and self-employment using exogenous variation from the introduction of Medicare Part D that reduced the out-of-pocket cost of prescription drugs and improved health outcomes in a difference-in-differences model using the American Community Survey.
Jeremy G, Moulton   +2 more
openaire   +2 more sources

Thesis on Medicare Part D

2019
The rapidly increasing healthcare spending, particularly on prescription drug, is a pressing issue in the United States and deserves comprehensive and in-depth analysis. In this dissertation, I investigate three topics that are highly relevant yet less researched under the current policy discussion of reforming Medicare by using empirical data from ...
openaire   +1 more source

Assessing the Effect of the Medicare Part D Redesign

JAMA
This Viewpoint focuses on the Manufacturer Discount Program, identifying 4 key themes of interest to policymakers that may be affected by its Part D redesign.
Rachel E, Sachs, Richard G, Frank
openaire   +2 more sources

Pharmacists, Medicare Part D, and the antikickback statute

American Journal of Health-System Pharmacy, 2006
It is well documented that the new Medicare prescription drug benefit is causing a great deal of confusion among those eligible for Medicare. What is receiving far less attention is the confusion among the pharmacists who are expected to help patients understand this drug benefit program.
openaire   +2 more sources

Where Are the Medicare Part D Claims Data?

Annals of Internal Medicine, 2008
The Centers for Medicare & Medicaid Services (CMS) have collected prescription drug claims data from all Medicare Part D plans since 2006, but these data are used only for limited purposes.
openaire   +2 more sources

Home - About - Disclaimer - Privacy